Structure of thymidylate kinase reveals the cause behind the limiting step in AZT activation.

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMID 9253404)

Published in Nat Struct Biol on August 01, 1997

Authors

A Lavie, I R Vetter, M Konrad, R S Goody, J Reinstein, I Schlichting

Articles citing this

3'-Azido-3'-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity. Biochem Pharmacol (2006) 1.25

Synthesis of nucleoside phosphate and phosphonate prodrugs. Chem Rev (2014) 1.13

Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. Cardiovasc Toxicol (2004) 1.11

Structural basis for efficient phosphorylation of 3'-azidothymidine monophosphate by Escherichia coli thymidylate kinase. Proc Natl Acad Sci U S A (1998) 1.09

3'-Azido-3'-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria. Biochem Pharmacol (2006) 1.02

Polyphosphate-dependent synthesis of ATP and ADP by the family-2 polyphosphate kinases in bacteria. Proc Natl Acad Sci U S A (2008) 0.98

3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants. J Virol (1998) 0.92

Thymidylate kinase of Mycobacterium tuberculosis: a chimera sharing properties common to eukaryotic and bacterial enzymes. Protein Sci (2001) 0.90

Structural basis for activation of alpha-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase. EMBO J (2000) 0.88

Role of nucleoside diphosphate kinase in the activation of anti-HIV nucleoside analogs. J Bioenerg Biomembr (2000) 0.88

Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding. Protein Sci (2006) 0.82

Effects of zidovudine and stavudine on mitochondrial DNA of differentiating 3T3-F442a cells are not associated with imbalanced deoxynucleotide pools. Antimicrob Agents Chemother (2008) 0.78

Restoration of the antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus by delivery of engineered thymidylate kinase to T cells. J Gen Virol (2008) 0.78

Characterization of Streptococcus pneumoniae thymidylate kinase: steady-state kinetics of the forward reaction and isothermal titration calorimetry. Biochem J (2002) 0.78

Therapy of HIV Infection: Current Approaches and Prospects. Acta Naturae (2017) 0.78

The yeast Cdc8 exhibits both deoxythymidine monophosphate and diphosphate kinase activities. FEBS Lett (2009) 0.75

AZT monophosphate knocks thymidylate kinase for a loop. Nat Struct Biol (1997) 0.75

Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system. Redox Biol (2017) 0.75

Articles by these authors

Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. EMBO J (1990) 6.51

Crystal structures of myoglobin-ligand complexes at near-atomic resolution. Biophys J (1999) 3.55

Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol (1991) 3.32

Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. Proc Natl Acad Sci U S A (1999) 3.30

Structure of the N6-adenine DNA methyltransferase M.TaqI in complex with DNA and a cofactor analog. Nat Struct Biol (2001) 3.04

The role of ATP in the functional cycle of the DnaK chaperone system. J Mol Biol (1995) 3.00

Kinetics of acto-S1 interaction as a guide to a model for the crossbridge cycle. J Muscle Res Cell Motil (1984) 2.91

Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet (2001) 2.87

Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J Infect Dis (1991) 2.86

Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site. EMBO J (1986) 2.85

Structure of the regulatory domain of scallop myosin at 2.8 A resolution. Nature (1994) 2.78

Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. Cell (1990) 2.77

The bottleneck in AZT activation. Nat Med (1997) 2.61

The magnesium ion-dependent adenosine triphosphatase of myosin. Two-step processes of adenosine triphosphate association and adenosine diphosphate dissociation. Biochem J (1974) 2.57

Kinetics of interaction of nucleotides with nucleotide-free H-ras p21. Biochemistry (1990) 2.55

Nucleotide-induced conformational changes in the ATPase and substrate binding domains of the DnaK chaperone provide evidence for interdomain communication. J Biol Chem (1995) 2.53

Adenylate kinase motions during catalysis: an energetic counterweight balancing substrate binding. Structure (1996) 2.53

Multiparameter single-molecule fluorescence spectroscopy reveals heterogeneity of HIV-1 reverse transcriptase:primer/template complexes. Proc Natl Acad Sci U S A (2003) 2.48

Solid-state synthesis and mechanical unfolding of polymers of T4 lysozyme. Proc Natl Acad Sci U S A (2000) 2.25

Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. J Biol Chem (1990) 2.24

Kinetic and structural analysis of the Mg(2+)-binding site of the guanine nucleotide-binding protein p21H-ras. J Biol Chem (1993) 2.23

The kinetic mechanism of Ran--nucleotide exchange catalyzed by RCC1. Biochemistry (1995) 2.20

Synthesis and properties of diastereoisomers of adenosine 5'-(O-1-thiotriphosphate) and adenosine 5'-(O-2-thiotriphosphate). Biochemistry (1976) 2.02

Dynamic properties of the Ras switch I region and its importance for binding to effectors. Proc Natl Acad Sci U S A (2001) 1.99

Structure of a ligand-binding intermediate in wild-type carbonmonoxy myoglobin. Nature (2000) 1.96

The second step of ATP binding to DnaK induces peptide release. J Mol Biol (1996) 1.96

pH gating of ROMK (K(ir)1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome. Proc Natl Acad Sci U S A (1999) 1.85

Formation of a transition-state analog of the Ras GTPase reaction by Ras-GDP, tetrafluoroaluminate, and GTPase-activating proteins. Science (1996) 1.85

Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Proc Natl Acad Sci U S A (1995) 1.84

The pre-hydrolysis state of p21(ras) in complex with GTP: new insights into the role of water molecules in the GTP hydrolysis reaction of ras-like proteins. Structure (1999) 1.80

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia (2007) 1.79

Proteins of contractile systems. Annu Rev Biochem (1976) 1.75

Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol (2001) 1.73

Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli. J Biol Chem (1989) 1.68

The interaction of bovine pancreatic deoxyribonuclease I and skeletal muscle actin. Eur J Biochem (1980) 1.67

Excitatory signaling in bacterial probed by caged chemoeffectors. Biophys J (1993) 1.66

Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC. Biochemistry (1997) 1.66

The role of cavities in protein dynamics: crystal structure of a photolytic intermediate of a mutant myoglobin. Proc Natl Acad Sci U S A (2000) 1.63

Tuning of chaperone activity of Hsp70 proteins by modulation of nucleotide exchange. Nat Struct Biol (2001) 1.61

Fractal morphology, imaging and mass spectrometry of single aerosol particles in flight. Nature (2012) 1.56

Cryptotomography: reconstructing 3D Fourier intensities from randomly oriented single-shot diffraction patterns. Phys Rev Lett (2010) 1.55

Synthetic inhibitors of adenylate kinases in the assays for ATPases and phosphokinases. Eur J Biochem (1975) 1.55

Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy. Biochemistry (1997) 1.49

Treadmill walking with partial body weight support versus floor walking in hemiparetic subjects. Arch Phys Med Rehabil (1999) 1.48

GrpE accelerates nucleotide exchange of the molecular chaperone DnaK with an associative displacement mechanism. Biochemistry (1997) 1.48

Treadmill training with partial body weight support and an electromechanical gait trainer for restoration of gait in subacute stroke patients: a randomized crossover study. Stroke (2002) 1.46

The binding constant of ATP to myosin S1 fragment. Eur J Biochem (1977) 1.44

A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis. Hum Mol Genet (1997) 1.44

Kinetics of interaction of Rab5 and Rab7 with nucleotides and magnesium ions. J Biol Chem (1996) 1.43

C-terminal truncation of p21H preserves crucial kinetic and structural properties. J Biol Chem (1989) 1.41

Kinetic and thermodynamic properties of the ternary complex between F-actin, myosin subfragment 1 and adenosine 5'-[beta, gamma-imido]triphosphate. Eur J Biochem (1982) 1.39

Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc Natl Acad Sci U S A (1996) 1.39

Transient kinetic studies on the interaction of Ras and the Ras-binding domain of c-Raf-1 reveal rapid equilibration of the complex. Biochemistry (1998) 1.35

The signal recognition particle receptor of Escherichia coli (FtsY) has a nucleotide exchange factor built into the GTPase domain. Proc Natl Acad Sci U S A (1997) 1.34

Iron center, substrate recognition and mechanism of peptide deformylase. Nat Struct Biol (1998) 1.34

The crystal structure of rna1p: a new fold for a GTPase-activating protein. Mol Cell (1999) 1.34

The mechanism of guanosine nucleotide hydrolysis by p21 c-Ha-ras. The stereochemical course of the GTPase reaction. J Biol Chem (1989) 1.30

Single-particle structure determination by correlations of snapshot X-ray diffraction patterns. Nat Commun (2012) 1.30

Scattering curves of ordered mesoscopic materials. J Phys Chem B (2005) 1.29

First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis (2010) 1.29

Vps9, Rabex-5 and DSS4: proteins with weak but distinct nucleotide-exchange activities for Rab proteins. J Mol Biol (2001) 1.28

The Cdc42/Rac interactive binding region motif of the Wiskott Aldrich syndrome protein (WASP) is necessary but not sufficient for tight binding to Cdc42 and structure formation. J Biol Chem (1998) 1.28

p21 with a phenylalanine 28----leucine mutation reacts normally with the GTPase activating protein GAP but nevertheless has transforming properties. J Biol Chem (1991) 1.28

Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res (2000) 1.27

Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet (2000) 1.27

Effector recognition by the small GTP-binding proteins Ras and Ral. J Biol Chem (1999) 1.25

Crystallization and preliminary X-ray analysis of the human c-H-ras-oncogene product p21 complexed with GTP analogues. J Mol Biol (1989) 1.24

RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms. FEBS Lett (1992) 1.24

Stereochemical aspects of the interaction of myosin and actomyosin with nucleotides. J Muscle Res Cell Motil (1980) 1.24

Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli. Proc Natl Acad Sci U S A (1981) 1.23

Crystal structure of the complex of UMP/CMP kinase from Dictyostelium discoideum and the bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-uridyl) pentaphosphate (UP5A) and Mg2+ at 2.2 A: implications for water-mediated specificity. Biochemistry (1996) 1.23

Refined model for primer/template binding by HIV-1 reverse transcriptase: pre-steady-state kinetic analyses of primer/template binding and nucleotide incorporation events distinguish between different binding modes depending on the nature of the nucleic acid substrate. J Mol Biol (1999) 1.22

Structures of active conformations of UMP kinase from Dictyostelium discoideum suggest phosphoryl transfer is associative. Biochemistry (1997) 1.22

Fluorescence and NMR investigations on the ligand binding properties of adenylate kinases. Biochemistry (1990) 1.22

Evolution of an enzyme active site: the structure of a new crystal form of muconate lactonizing enzyme compared with mandelate racemase and enolase. Proc Natl Acad Sci U S A (1998) 1.22

Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site. Biochem Biophys Res Commun (1998) 1.22

Assessment of the ATP binding properties of Hsp90. J Biol Chem (1996) 1.21

HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity. J Biol Chem (2000) 1.19

Crystal structure of the GAP domain of Gyp1p: first insights into interaction with Ypt/Rab proteins. EMBO J (2000) 1.19

Stereochemistry of the elongation factor Tu X GTP complex. Eur J Biochem (1983) 1.19

C-terminal regions of Hsp90 are important for trapping the nucleotide during the ATPase cycle. J Mol Biol (2000) 1.18

Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras. Biochemistry (1993) 1.17

A sensitive fluorescence monitor for the detection of activated Ras: total chemical synthesis of site-specifically labeled Ras binding domain of c-Raf1 immobilized on a surface. Chem Biol (2001) 1.17

Interaction of fluorescently labeled dideoxynucleotides with HIV-1 reverse transcriptase. Biochemistry (1991) 1.16

Cross-bridges and the mechanism of muscle contraction. Biochim Biophys Acta (1983) 1.16

Biochemical and biological consequences of changing the specificity of p21ras from guanosine to xanthosine nucleotides. Oncogene (1996) 1.15

Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil (1998) 1.14

DNA sequencing using alpha-thiodeoxynucleotides. Methods Enzymol (1987) 1.14